A carregar...

Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count

BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) in childhood is a rare disease with frequent progression to end-stage renal disease and a high recurrence after kidney transplantation. Eculizumab, a humanized monoclonal antibody that binds to complement protein C5, may be beneficial in the trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dorresteijn, Eiske M., van de Kar, Nicole C. A. J., Cransberg, Karlien
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362716/
https://ncbi.nlm.nih.gov/pubmed/22399074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-012-2130-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!